End-Stage Renal Disease (ESRD)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients who are medically required to receive contrast media. (The decision on the amount of contrast media administered in the individual patient is based on clinical requirements.) The patients who have no history of allergy against contrast media PD patients with urine volume >100mL/day
Exclusion criteria
Exclusion criteria: allergy against contrast media severe hyperthyroidism pregnancy or possibility of pregnancy hybrid (PD+HD) therapy less than 20 y.o. poor patient compliance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. residual renal function at 24-48 h. after administration of radio contrast media 2. residual renal function at 2-4 weeks after administration of radio contrast media | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. residual renal function at 6 month after administration of radio contrast media 2. effects of usage of fluid administration 3. effects of amount of radio contrast media 4. effects of residual renal function at administration of radio contrast media | — |
Countries
Japan
Contacts
Nagoya University Nephrology and Renal Replacement Therapy